by preyes1 | Jul 22, 2019 | Uncategorized
Congratulations to Dr. Giger on the recent acquisition of QuantX, by biotech incubator Paragon Biosciences. QuantX is an FDA-cleared artificially intelligent diagnostic tool, which aims to help radiologists accurately identify breast cancer in patients. Quantitative...
by preyes1 | May 28, 2019 | HIRO
The HIRO has published a new journal article! The article highlights challenges to the management of clinical trial imaging, and includes several recommendations to tackle these issues industry-wide. The article, titled “Critical Challenges to the Management of...
by preyes1 | May 7, 2019 | Uncategorized
We are excited to announce that Dr. Maryellen Giger has been nominated and elected to be a Fellow of the International Academy of Medical and Biological Engineering (IAMBE). With this election, Dr. Giger is being recognized for her distinguished contributions to and...
by preyes1 | Mar 1, 2019 | Uncategorized
Dr. Gregory Karczmar, is featured in The Forefront, detailing his personal story and advocacy for early cancer screening. Dr. Karczmar, has dedicated much of his career to developing better and more affordable screening methods for early detection of breast and...
by preyes1 | Jan 9, 2019 | Uncategorized
The George Schulz Innovation Fund of the Polsky Center has selected QMIS to be awarded up to $200,000 for its novel MRI software for prostate cancer detection that creates a heat map of potential cancer. The tool utilizes new research in image acquisition and...
